Nvidia: Analysts Anticipate $5.8 Billion In Q3 Revenues

Nvidia Corp (NASDAQ: NVDA) will be reporting their fiscal third quarter financial results May 26th after market close. Analysts have a consensus $669.16 12-month price target on the company, via a total of 41 analysts, with ten analysts having strong buy ratings, 24 analysts having buy ratings, six have hold ratings and one analyst has a sell rating. The street high comes is a $800 price target from Needham, and the lowest target sits at $380 from BNP Paribas.

29 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 29 analysts is $5.8 billion; this number has been revised upwards from $5.27 billion at the start of the year. The highest revenue estimate is $6.243 billion, while the lowest is $5 billion.

The analyst consensus for net income for the third quarter is $2.227 billion, this is up from the start of the year at $2 billion. The highest net income estimate is $2.489 billion, while the lowest is $1.833 billion.

Onto EBITDA estimates, there are currently only 5 analysts who have third quarter EBITDA estimates. The mean is currently $2.771 billion, with this number having been revised higher from $2.458 billion at the start of the year. The street high estimate currently sits at $2.898 billion in EBITDA and the lowest is $2.526 billion.

Analysts estimate that quarterly earnings per share will come in at $3.53, with this number being higher from the $3.15 estimate at the start of the year. The street high is $3.95 and the lowest estimate is $2.90 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Gold To Spin Out Mt. Margaret Copper-Gold Project Into US-Focused Entity

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Related News

Target: Analyst Consensus First Quarter Estimates

Target Corporation (NYSE: TGT) will be reporting their first-quarter financial results May 19th before market...

Tuesday, May 18, 2021, 06:29:00 PM

Well Health: PI Financial Raises Price Target To $7.00 On Back Of Circle Acquisition

This week WELL Health Technologies (TSX: WELL) announced that they are expanding into the US...

Friday, September 4, 2020, 01:38:00 PM

Beyond Meat: Analysts Lower Price Targets Following Disappointing Earnings

Beyond Meat (NASDAQ: BYND) has been a laggard this year, with its year-to-date performance currently...

Sunday, May 16, 2021, 02:13:00 PM

Sundial: Canaccord Drops Target To $0.50 Following Q1 Results

On Monday, Sundial Growers Inc. (Nasdaq: SNDL) reported its first quarter financial results. The company...

Wednesday, May 18, 2022, 03:44:00 PM

Trulieve Cannabis: Analyst Q1 Consensus Estimates

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their first quarter financials before...

Wednesday, May 12, 2021, 04:01:00 PM